Neurodegenerative Drugs Market Size to Expand Significantly by the End of 2028
The growth of the neurodegenerative drugs market is primarily driven by the increasing prevalence of Alzheimer's and Parkinson's diseases. Expanding the geriatric populace across geographies is likely to drive market growth at a significant rate during the review period. In addition to this, increasing investment in research and development activities to develop new treatment methods is likely to create lucrative opportunities for the players operating in the global neurodegenerative drugs market in the coming years.